Compare Cronos Group Inc (CRON) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? Cronos Group Inc trades at $3.08 (market cap $1.11B), while Consumer Staples Select Sector SPDR Fund trades at $84.65. The key difference: Cronos Group Inc is trading nearer its 52-week high, Consumer Staples Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| CRON | XLP | |
|---|---|---|
Market Cap | $1.11B | — |
Sector | Health | — |
52-Week High | $3.27 | $90.00 |
52-Week Low | $2.30 | $75.61 |
Enterprise Value | $310.67M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.10 with a 0.98% daily gain, showing bullish technical momentum. The company delivered strong Q2 2026 results with 58% YoY revenue growth and earnings beat, while maintaining #1 market share in Canadian vapes and edibles. Despite negative net income in 2025, revenue growth accelerated to $147M with improving margins. Technical indicators show bullish moving averages but RSI suggests potential overbought conditions near $3 resistance.
Outlook remains positive with international expansion and European cannabis legalization driving growth, though competitive pressures and execution risks persist. Analyst consensus is mixed with 60% hold ratings, reflecting cautious optimism about CRON's turnaround trajectory from previous losses to projected 39% profit margin by 2026.
XLP trades at $85.12 with minimal daily movement (+0.01%). The ETF maintains a bullish technical outlook with strong moving average signals and oversold RSI conditions. Analyst consensus is unanimously positive with 100% buy ratings. Recent news highlights consumer staples sector resilience amid market uncertainty, with Coca-Cola's strong earnings demonstrating the defensive appeal of staple goods companies.
The defensive nature of consumer staples provides stability during market volatility, though limited financial ratio data requires deeper fundamental analysis. Key risks include sector rotation away from defensive plays and macroeconomic pressures on consumer spending. The 2.6% dividend yield offers income appeal for risk-averse investors seeking market exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Consumer Staples Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.
Read more on XLP →
